TP53 and hepatocellular carcinoma: There is also evidence that p53 and YAP1 cooperate in chemotherapy efficacy, with direct binding of YAP1 and p53 to each other’s promoters, increasing their expression in response to chemotherapy in hepatocellular carcinoma cells [68].